The Ideal Candidate:
- Innovative
- Strategic
- Team Leader
- Excellent Communicator
What You'll Do:
- Provide leadership for client strategies in Market Access and HEOR programs, including evidence generation, pricing, value communication, and HTA policy requirements, working with internal and external stakeholders.
- Drive business development for Market Access programs, contributing to WEP Market Access strategic consulting growth across ATMPS, Oncology, and Rare Diseases.
- Secure new client contracts and lead projects, leveraging WEP infrastructure to ensure successful delivery.
- Develop a ‘Key Account’ management approach to forecast new business, manage Total Contract Value (TCV), and shape client legacy strategies.
- Build and enhance WEP Clinical capabilities to support client transitions from clinical trials, OLE, EAP, NPP, and early access programs to commercial access and positive payer recommendations.
- Create a preferred partner environment for clients, ensuring strategic support for asset commercialization and licenced indications.
- Lead client strategies on marketing authorisations, early access schemes, competitor analysis, pricing/reimbursement, value propositions, and innovative pricing implementation.
- Manage client programs from scoping to delivery, including proposals, SOW agreements, and allocation of internal or external Market Access resources.
- Develop MAx team capabilities in HEOR, value propositions, HTA dossier development, health economic modeling, and EU Joint Clinical Assessment (JCA) updates, while collaborating cross-functionally with other departments.
- Oversee third-party vendor management, forecasting, budgeting/P&L, and drive WEP Market Access objectives across business, team, and personal performance.
What You'll Need:
- Bachelor’s degree in a Scientific or Business discipline; MSc in Health Economics or Health Policy is advantageous
- Leadership experience within a Market Access division or business unit in a pharmaceutical company
- Budgetary and P&L responsibilities, including forecasting and overall business management
- Commercial experience in pharmaceuticals, specifically in specialized therapies such as Oncology, Cell & Gene, and Rare Diseases
- Experience with commercial contracting with clients, vendors, and third-party service providers
- Product lifecycle management expertise, including new product introduction and commercialization
- Strong network across European reimbursement agencies
- Proven leadership in people management, skill development, and career planning
- Ability to remain in a statutory position for extended periods as part of normal day-to-day activities, with reasonable adjustments considered where appropriate
Skills Required
- Bachelor's degree in a Scientific or Business discipline
- MSc in Health Economics or Health Policy
- Leadership experience within a Market Access division or business unit in a pharmaceutical company
- Budgetary and P&L responsibilities, including forecasting and overall business management
- Commercial experience in pharmaceuticals, specifically in specialized therapies such as Oncology, Cell & Gene, and Rare Diseases
- Experience with commercial contracting with clients, vendors, and third-party service providers
- Product lifecycle management expertise, including new product introduction and commercialization
- Experience in Market Access and HEOR programs, including evidence generation, pricing, value communication, and HTA policy requirements
- Experience with HEOR methodologies, HTA dossier development, health economic modeling, and EU Joint Clinical Assessment updates
- Strong network across European reimbursement agencies
- Proven leadership in people management, skill development, and career planning
- Experience managing third-party vendors, forecasting, budgeting, and P&L oversight
- Ability to remain in a statutory position for extended periods as part of normal day-to-day activities
What We Do
We are a rapidly growing niche pharmaceutical services company operating in four key sectors:- Managed Access Programs (MAP) Unlicensed Medicines Access Clinical Trial Sourcing Reference Product Supply. Our goal is to provide positive measurable outcomes to patients and sponsors but above all else we want to be known as your “trusted partner” and an extension of your team. •UK headquarters established in London in 2008. •US Headquarters established in Research Triangle Park, North Carolina in 2012. •Our team has many years of pharmaceutical, clinical and regulatory experience gained in companies such as Pfizer, AZ, MSD, GSK, UDG Healthcare, Waymade, Sanofi, Quintiles & Walgreens Boots Alliance. •Our facilities have been inspected & licensed by the MHRA, UK Home Office, FDA and all necessary local approval bodies. •We are also approved to handle and distribute controlled substances. •We are compliant with all relevant GMDP regulations and operate to a high standard of medicines supply. •We operate under a comprehensive Quality Management System with robust and compliant standard operating procedures (SOPs) and policies. •Our customers and partners include Pharma, Biotechs, Generic and Biosimilar Developers, CROs and Healthcare and Hospital authorities. •We are fully committed to a culture of continual development and strive to service our partners needs beyond their expectations We would be happy to answer any questions that you may have regarding WEP Clinical and our products and services.

.png)






